查看中文
yxu@cooley.com
Yunxiang Xu represents companies, investment banks and private equity funds in IPOs and other corporate transactions.
Download full bio
Cryofocus Medtech – HK$210 Million IPO
Asymchem Agrees to Acquire Snapdragon Chemistry
Capital Markets
Mergers & Acquisitions
Private Equity
Technology
Telecommunications & Wireless
Life Sciences
Asia
Harvard Law SchoolLLM, 2021
China University of Political Science and LawLLM, 2017
Wuhan UniversityLLB, 2013
Cryofocus Medtech – HK$210 Million IPO December 30, 2022
+86 21 6030 0653 +86 21 6030 0653
Locations